Practice Patterns Study News Today

More than half of patients with nondialysis chronic kidney disease reported bothersome pruritus, or “itchy skin.” Pruritus, or “itchy skin,” also affects patients with nondialysis chronic kidney disease (CKD) and is tied with worse outcomes.

Patients on maintenance hemodialysis classified as having a high erythropoietin resistance index had a greater risk of all-cause mortality.

Investigators report results of their analysis of patients in the DOPPS and PDOPPS. Transfusion rates are high within the first few months of hemodialysis, but not peritoneal dialysis.

Low uptake of conservative kidney management appears to be due to barriers at multiple points of clinical care, according to investigators. A US study describes the discussions and resources around providing conservative kidney management to select patients with kidney failure.

Patients on hemodialysis treated with ESAs who have higher hemoglobin variability are at higher risk for all-cause mortality and particularly infectious events.

CKD-aP patients receiving maintenance hemodialysis reported adverse clinical events in line with their pruritus severity and were found to be at greater risk of all-cause mortality, all-cause hospitalization, and cardiovascular events.

Investigators assessed the benefits of cinacalcet (approved in 2004) vs etelcalcetide (approved in 2017) for patients on hemodialysis.

The 2019 landmark PIVOTAL trial that established the safety and efficacy of higher-dose iron in patients on hemodialysis had little discernable impact on US practice, which already used higher doses.

Recent study findings could explain the preponderance of men in the dialysis population.

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and FibroGen, Inc. (Nasdaq: FGEN, CEO: Enrique Conterno,...